Team:Westminster/Notebook

From 2012.igem.org

(Difference between revisions)
Line 1: Line 1:
-
<!--- The Mission, Experiments --->
 
-
 
<html>
<html>
 +
<head>
<head>
-
<style type="text/css">
+
 
-
body {
+
<meta http-equiv="content-type" content="text/php; charset=utf-8" />
-
    background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff
+
 
-
}
+
<style type="text/css">
-
a {
+
@import url 'http://yui.yahooapis.com/2.9.0/build/reset/reset-min.css';
-
    color: #66c9c1;
+
ul {
-
}
+
list-style: none;
-
a:visited, td a:visited {
+
}
-
    background: #ffeebb !important;
+
body {
-
}  
+
font-family: "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif;  
-
table, p {
+
font-weight: 300;
-
    font-family: "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif;  
+
background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff;
-
    font-weight: 300;
+
color: #666666;
-
    font-size: 11pt;
+
}
-
    color: #666666;
+
h1, h2 {
-
}
+
color: #ff0000;
-
div#globalWrapper > div {
+
font-size: 18pt;
-
    box-shadow: 0 0 17px -4px #666666;
+
margin-bottom: 0.5em;
-
}
+
}
-
div#content {
+
h2 {
-
    width: 945px;
+
font-size: 16pt;
-
    padding: 15px;
+
}
-
}
+
h3 {
-
ul#navigation {
+
color: #ff0000;
-
    list-style: none;
+
}
-
    overflow: auto;
+
p {
-
}
+
 
-
ul#navigation > li {
+
}
-
    background: url("http://www.westminsterigem.com/files/theme/nav-sep.png") no-repeat scroll right 10px transparent;
+
a {
-
    float: left;
+
-
    height: 25px;
+
}
-
    padding: 0px 15px;
+
#p-logo {
-
}
+
background: #444444;
-
ul#navigation > li.first-item {
+
}
-
    padding-left: 0px;
+
div#top-section,
-
}
+
div#content {
-
ul#navigation > li.last-item {
+
box-shadow: 0px 0px 17px -4px #666666;
-
    background: none;
+
}
-
    padding-right: 0px;
+
div#wrapper {
-
}
+
position: relative;
-
ul#navigation a.navlink {
+
width: 885px;
-
    line-height: 25px;
+
font-size: 12pt;
-
    list-style: none outside none;
+
padding: 50px 40px;
-
    color: #545454;
+
margin: 0 auto;
-
    border-top: 3px solid transparent;
+
background: #ffffff;
-
    padding: 3px 15px;
+
}
-
}
+
div#header {
-
ul#navigation a.navlink:hover {
+
height: 185px;
-
    border-top: 3px solid #66c9c1;
+
}
-
    color: #545454;
+
div#header div#logo {
-
    text-decoration: none;
+
position: relative;
-
}
+
width: 400px;
-
div#footer-box {
+
height: 125px;
-
    border-radius: 0 0 5px 5px;
+
margin: 0 auto;
-
}
+
}
-
</style>
+
div#header div#logo {
 +
margin-bottom: 20px;
 +
}
 +
div#navigation {
 +
width: 100%;
 +
height: 40px;
 +
background: #000000;
 +
}
 +
ul#navigation-list {
 +
height: 40px;
 +
line-height: 40px;
 +
overflow: hidden;
 +
}
 +
ul#navigation-list > li {
 +
float: left;
 +
}
 +
ul#navigation-list > li > ul {
 +
position: absolute;
 +
display: none;
 +
background: #000000;
 +
z-index: 100000;
 +
}
 +
ul#navigation-list > li > ul.submenu {
 +
margin: 0;
 +
}
 +
ul#navigation-list > li > ul.submenu li {
 +
padding: 5px 0px;
 +
}
 +
ul#navigation-list a.navlink {
 +
color: #ffffff;
 +
font-weight: bold;
 +
display: block;
 +
padding: 0px 14px;
 +
text-decoration: none;
 +
}
 +
ul#navigation-list a.navlink.active,
 +
ul#navigation-list a.navlink:hover {
 +
color: #ff0000;
 +
}
 +
div#home-main-image {
 +
text-align: center;
 +
}
 +
div#home-main-image img {
 +
width: 885px;
 +
height: 300px;
 +
margin-bottom: 20px;
 +
border-radius: 20px;
 +
}
 +
div.text-box {
 +
background: #444444;
 +
color: #ffffff;
 +
padding: 15px 20px;
 +
border-radius: 10px;
 +
}
 +
div.three-columns {
 +
padding-left: 20px;
 +
overflow: auto;
 +
}
 +
div.column, img.column {
 +
float: left;
 +
width: 235px;
 +
margin: 10px 0px 50px 20px;
 +
border-radius: 10px;
 +
}
 +
div.centered {
 +
position: relative;
 +
width: 400px;
 +
margin: 10px auto;
 +
}
 +
div#footer-box {
 +
border-radius: 0 0 5px 5px;
 +
}
 +
</style>
 +
 
 +
<script type="text/javascript" src="http://code.jquery.com/jquery-1.8.2.min.js"></script>
 +
<script type="text/javascript">
 +
$('document').ready(function() {
 +
$('li.submenu-holder').hover(function() {
 +
$(this).children('ul.submenu').stop(true).fadeIn('slow');
 +
}, function() {
 +
$(this).children('ul.submenu').stop(true).fadeOut('slow');
 +
});
 +
});
 +
</script>
 +
 
</head>
</head>
<body>
<body>
-
<ul id="navigation">
 
-
  <li class="first-item"><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li>
 
-
  <li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Project"class="navlink">Project</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink">Notebook</a></li>
 
-
  <li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
 
-
  <li class="last-item"><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li>
 
-
</ul>
 
-
</body>
 
-
</html>
 
 +
<div id="wrapper">
-
You should make use of the calendar feature on the wiki and start a lab notebook. This may be looked at by the judges to see how your work progressed throughout the summer. It is a very useful organizational tool as well.
+
<div id="header">
 +
<div id="logo">
 +
<a href="https://2012.igem.org/Team:Westminster">
 +
<img src="https://static.igem.org/mediawiki/2012/1/1e/Westminster-logo.png" alt="iSTEM" title="Back to home!" />
 +
</a>
 +
</div><!-- #logo -->
 +
<div id="navigation">
 +
<ul id="navigation-list">
 +
<li><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li>
 +
<li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li>
 +
<li class="submenu-holder">
 +
<a href="https://2012.igem.org/Team:Westminster/Project/Overview"class="navlink active">Project</a>
 +
<ul class="submenu">
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink active">Overview</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Problem"class="navlink">The Problem</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Experiments"class="navlink">Experiments</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Protocols"class="navlink">Protocols</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Results"class="navlink">Results</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
 +
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Journal"class="navlink">Journal</a></li>
 +
</ul>
 +
</li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink">Notebook</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li>
 +
<li><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li>
 +
</ul><!-- #navigation-list -->
 +
</div><!-- #navigation -->
 +
</div><!-- #header -->
 +
 
 +
<div id="the-content">
 +
<div id="home-main-image">
 +
<img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" />
 +
</div><!-- #home-main-image -->
 +
 
 +
<div id="home-main-text">
 +
<h2>Lorem Ipsum</h2>
 +
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
 +
<h2>Lorem Ipsum</h2>
 +
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
 +
<h2>Lorem Ipsum</h2>
 +
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
 +
</div><!-- #home-main-text -->
 +
 
 +
</div><!-- #the-content -->
 +
 
 +
</div><!-- #wrapper -->
 +
 
 +
 
 +
</body>
 +
 
 +
</html>

Revision as of 20:10, 25 September 2012

Welcome

Lorem Ipsum

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

Lorem Ipsum

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

Lorem Ipsum

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.